Schizophrenia - A mild encephalitis?;Schizophrenie - eine milde Enzephalitis?

Fortschritte der Neurologie Psychiatrie

Volumn 81, Issue 5, 2013, Pages 250-259

  Bechter, K ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

cerebrospinal fluid (CSF); low level neuroinflammation; mild encephalitis; schizophrenia

Indexed keywords

ARTICLE; ENCEPHALITIS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; IMMUNE SYSTEM; MICROGLIA; MILD ENCEPHALITIS; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; SCHIZOPHRENIA;

AUTOIMMUNE DISEASES; BORNA DISEASE; CENTRAL NERVOUS SYSTEM INFECTIONS; ENCEPHALITIS; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84878106996     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0033-1335253     Document Type: Article

References (155)

1. Bechter K. "Mild Encephalitis" - Brain-Organic Pathologies between Neurologic and Psychiatric Disease. Neurol Psychiatry Brain Res: 2009; 16 01 5 6
2. Bechter K. Diagnosis of infectious or inflammatory psychosyndromes. The Open Neurology Journal: 2012; 6 01 113 118
3. Schmitt A. et al. Reduction of gyrification index in the cerebellar vermis in schizophrenia: a post-mortem study. World J Biol Psychiatry: 2011; 12 01 99 103
4. Swedo S. E. et al. Streptococcal infection, Tourette syndrome, and OCD: is there a connection? PANDAS: horse or zebra? Neurology: 2010; 74 1397 1398 author reply 1398-1399
5. Bechter K. et al. Therapy-resistant depression with fatigue. A case of presumed streptococcal-associated autoimmune disorder. Nervenarzt: 2007; 78: 338: 340 341
6. Huber G. Klinik und Psychopathologie der organischen Psychosen. In: Kisker K. P. et al. (ed) Psychiatrie der Gegenwart. Berlin Heidelberg New York Springer: 1972; 71 146
7. Bonhoeffer K. Die exogenen Reaktionstypen. Arch Psychiat Nervenkr: 1917; 58 58 70
8. Blazer D. G., van Nieuwenhuizen A. O. Evidence for the diagnostic criteria of delirium: an update. Curr Opin Psychiatry: 2012; 25 239 243
9. Coid J. W. Aetiological risk factors for personality disorders. Br J Psychiatry: 1999; 174 530 538 (Pubitemid 29278688)
10. Raeder M. B. et al. Arachnoid cysts cause cognitive deficits that improve after surgery. Neurology: 2005; 64 160 162 (Pubitemid 40082960)
11. Bechter K. et al. Personality disorders improved after arachnoid cyst neurosurgery, then rediagnosed as "minoro" organic personality disorders. Psychiatry Res: 2010; 184 196 200
12. Propping P. (ed). Psychiatrische Genetik. Befunde und Konzepte. Heidelberg Springer Verlag GmbH: 1989
13. Lesch K. P., Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron: 2012; 76 175 191
14. Irani S. R., Vincent A. Autoimmune encephalitis - new awareness, challenging questions. Discov Med: 2011; 11 449 458
15. Dalmau J., Bataller L. Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am: 2006; 20 1319 1335 (Pubitemid 44739218)
16. Pedrosa D. J. et al. Anti-NMDA receptor encephalitis: a neurological and psychiatric emergency. Fortschr Neurol Psychiatr: 2012; 80 29 35
17. Steiner J. et al. Increased Prevalence of Diverse N-Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia: Specific Relevance of IgG NR1a Antibodies for Distinction From N-Methyl-D-Aspartate Glutamate Receptor Encephalitis. JAMA Psychiatry: 2013; 70 271 278
18. Meyding-Lamadé U., Bechter K. Meningoencephalitiden als Ursache psychiatrischer Syndrome - Psychisch krank durch Mikroben im Hirn. InFo Neurologie & Psychiatrie: 2005; 7 38 45
19. Gross G., Huber G., Linz M. Zur Frage der symptomatischen Schizophrenie und Zyklothymie. Zbl Neurol: 1989; 251 323 332
20. Huber G. Zur nosologischen Differenzierung lebensbedrohlicher katatoner Psychosen. Schweiz. Arch Neurol Psychiatrie: 1955; 74 216 244
21. Bechter K. Basic symptoms in symptomatic schizophrenia. Neurol Psychiatry Brain Res: 2002; 10 35 40 (Pubitemid 36033743)
22. Graus F., Dalmau J. Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol: 2007; 20 732 737 (Pubitemid 350085019)
23. Irani S., Lang B. Autoantibody-mediated disorders of the central nervous system. Autoimmunity: 2008; 41 55 65
24. Anderson N. E., Barber P. A. Limbic encephalitis - a review. J Clin Neurosci: 2008; 15 961 971
25. Lancaster E., Dalmau J. Neuronal autoantigens pathogenesis - associated disorders and antibody testing. Nat Rev Neurol: 2012; 8 380 390
26. Lennox B. R., Coles A. J., Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry: 2012; 200 92 94
27. Glaser C. A. et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis: 2006; 43 1565 1577 (Pubitemid 44901899)
28. Wildemann B., Oschmann P., Reiber H. (eds). Laboratory Diagnosis in Neurology. Stuttgart Thieme: 2010
29. Osborn A. G., Salzman K. L., Barkovich A. J. (eds). Diagnostic Imaging: Brain. Lippincott Williams & Wilkins: 2010
30. Johnson R. T. (ed). Viral infections of the nervous system. New York. Raven: 1982
31. Aurelius E. Herpes simplex encephalitis. Early diagnosis and immune activation in the acute stage and during long-term follow-up. Scand J Infect Dis Suppl: 1993; 89 3 62 (Pubitemid 23269397)
32. Bechter K., Hodgkiss A. Research strategies in "slowo" infections in psychiatry. Hist Psychiatry: 1995; 6 503 511
33. Torrey E. F., Yolken R. H. Schizophrenia and toxoplasmosis. Schizophr Bull: 2007; 33 727 728
34. Nathan C. Points of control in inflammation. Nature: 2002; 420 846 852 (Pubitemid 36019637)
35. Medzhitov R. Origin and physiological roles of inflammation. Nature: 2008; 454 428 435
36. O'Callaghan J. P., Sriram K., Miller D. B. Defining " neuroinflammationo" Ann N Y Acad Sci: 2008; 1139 318 330
37. Swedo S. E. et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry: 1998; 155 264 271 (Pubitemid 28074291)
38. Bechter K. et al. Therapieresistente Depression mit Fatigue. Fall einer vermutlichen streptokokkenassoziierten Autoimmunkrankheit. Nervenarzt: 2007; 78 338, 340 341
39. Kramer K. et al. TNF-Overexpression in Borna Disease Virus-Infected Mouse Brains Triggers Inflammatory Reaction and Epileptic Seizures. PLoS One: 2012; 7 e41476
40. Bechter K. Mild encephalitis underlying psychiatric disorder - A reconsideration and hypothesis exemplified on Borna Disease. Neurol Psychiatry Brain Res: 2001; 9 55 70 (Pubitemid 34309278)
41. Bechter K., Schuttler R., Herzog S. Borna disease virus: possible causal agent in psychiatric and neurological disorders in two families. Psychiatry Res: 1992; 42 291 294
42. Hafner H. Epidemiology of schizophrenia. The disease model of schizophrenia in the light of current epidemiological knowledge. Eur Psychiatry: 1995; 10 217 227
43. Herzog S. et al. Molecular characterization of Borna disease virus from naturally infected animals and possible links to human disorders. Arch Virol Suppl: 1997; 13 183 190 (Pubitemid 127502142)
44. Dean B. Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies. Int J Neuropsychopharmacol: 2010; 14 997 1012
45. Horie M. et al. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature: 2010; 463 84 87
46. Belyi V. A., Levine A. J., Skalka A. M. Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes. PLoS Pathog: 2010; 6 e1001030
47. Dalman C. et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry: 2008; 165 59 65 (Pubitemid 351704553)
48. Eaton W. W. et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry: 2006; 163 521 528 (Pubitemid 44469397)
49. Benros M. E., Mortensen P. B., Eaton W. W. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci: 2012; 1262 56 66
50. McGrath J. et al. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev: 2008; 30 67 76
51. Zammit S. et al. Individuals, schools, and neighborhood: a multilevel longitudinal study of variation in incidence of psychotic disorders. Arch Gen Psychiatry: 2010; 67 914 922
52. van Os J., Kenis G., Rutten B. P. The environment and schizophrenia. Nature: 2010; 468 203 212
53. Kirkbride J. B. et al. Incidence of schizophrenia and other psychoses in England, 1950-2009: A systematic review and meta-analyses. PLOS ONE: 2012; 7 e1660
54. Benros M. et al. Autoimmune diseases and severe infections as risk factors for schizophrenia - A 30-year population-based register study. Am J Psychiatry: 2011; 168 1303 1310
55. Ackerknecht E. H. Causes and pseudocauses in the history of diseases. in Stevenson L. G. (ed) A celebration of medical history. Baltimore, London. Johns Hopkins University Press: 1982; 19 31
56. Uher R. The role of genetic variation in the causation of mental illness: an evolution-informed framework. Mol Psychiatry: 2009; 14 1072 1082
57. Caspi A. et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry: 2010; 167 509 527
58. Graham A. L. et al. Fitness correlates of heritable variation in antibody responsiveness in a wild mammal. Science: 2010; 330 662 665
59. Bechter K. Updating the Mild Encephalitis Hypothesis of Schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry: 2013; 42 71 91
60. Stefansson H. et al. Common variants conferring risk of schizophrenia. Nature: 2009; 460 744 747
61. Raison C. L., Miller A. H. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry: 2013; 18 15 37
62. Kornhuber H. H., Kornhuber J. A neuroimmunological challenge: schizophrenia as an autoimmune disease. Arch Ital Biol: 1987; 125 271 272
63. Fathman C. G. et al. An array of possibilities for the study of autoimmunity. Nature: 2005; 435 605 611 (Pubitemid 40825500)
64. Drexhage R. C. et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother: 2010; 10 59 76
65. Conrad K. The predictive relevance of autoantibodies. in Conrad K. et al. (eds) From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Lengerich Pabst Science Publishers: 2007
66. Benedetti F. et al. Emotional reactivity in chronic schizophrenia: structural and functional brain correlates and the influence of adverse childhood experiences. Psychol Med: 2011; 41 509 519
67. Lederbogen F. et al. City living and urban upbringing affect neural social stress processing in humans. Nature: 2011; 474 498 501
68. Juckel G. et al. Microglial activation in a neuroinflammational animal model of schizophrenia - a pilot study. Schizophr Res: 2011; 131 96 100
69. Meyer U. Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry: 2013; 42 20 34
70. Marshall B. J. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev Infect Dis: 1990; 12 01 S87 S93 (Pubitemid 20060289)
71. Lawn S. D., Zumla A. I. Tuberculosis. Lancet: 2011; 378 57 72
72. Müller N., Bechter K. The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings. Neurol Psychiatry Brain Res: 2013; in revision
73. Carlson G. D. et al. Cerebral spinal fluid pressure: effects of body position and lumbar subarachnoid drainage in a canine model. Spine (Phila Pa 1976): 2003; 28 119 122 (Pubitemid 36110076)
74. Bechter K., Bogerts B. Inflammatory and Neuroimmunological Aspects in Psychiatric Disorders. Highlights of the 9th Psychoimmunology Expert Meeting: Neuropsychoimmunology of Psychoses. Immune and Inflammatory Aspects of Psychoses. In Vivo: 2007; 21 917 923
75. Hobbs J. A. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex. J Neurovirol: 2006; 12 190 199 (Pubitemid 44574594)
76. Bechter K. Virus Infection as a Cause of Inflammation in Psychiatrie Disorders. in Halaris A., Leonard B. (eds) Inflammation in Psychiatry. Mod Trends Pharmacopsychiatry. Basel S. Karger AG: 2013; 49 60
77. Yolken R. H. et al. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res: 2011; 128 61 65
78. Dickerson F. B. et al. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry: 2003; 60 466 472 (Pubitemid 36539055)
79. Dickerson F. B. et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry: 2004; 55 588 593 (Pubitemid 38315032)
80. Dickerson F. et al. Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophr Bull: 2007; 33 737 740 (Pubitemid 47343714)
81. Bechter K., Bogerts B., Steiner J. Abstracts of the 10th Psychoimmunology Expert Meeting. Neurol Psychiatry Brain Res: 2009; 16 (Suppl 1)
82. Drexhage R. C. et al. An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. Int J Neuropsychopharmacol: 2011; 14 746 755
83. Brown D. A., Sawchenko P. E. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol: 2007; 502 236 260 (Pubitemid 46595397)
84. Bartholomaus I. et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature: 2009; 462 94 98
85. Ransohoff R. M. Immunology: In the beginning. Nature: 2009; 462 41 42
86. Lucchinetti C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med: 2011; 365 2188 2197
87. Perron H., Lang A. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin Rev Allergy Immunol: 2010; 39 51 61
88. Leboyer M. et al. Human endogenous retrovirus type W (HERV-W) in schizophrenia: A new avenue of research at the gene-environment interface. World J Biol Psychiatry: 2013; 14 80 90
89. Oleszak E. L. et al. Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev: 2004; 17 174 207 (Pubitemid 38120933)
90. Pruss H. et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol: 2012; 72 902 911
91. Klosterkötter J. Early detection of schizophrenia. Neurol Psychiatry Brain Res: 2011; 17 1 10
92. Reichenberg A. et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry: 2010; 167 160 169
93. Bayer T. A., Falkai P., Maier W. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis" J Psychiatr Res: 1999; 33 543 548
94. Brown A. S. et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry: 2004; 61 774 780 (Pubitemid 39031117)
95. Meyer U. et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci: 2006; 26 4752 4762 (Pubitemid 44315314)
96. Brown A. S. et al. AE Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry: 2001; 49 473 486 (Pubitemid 32226406)
97. Brown A. S. Further evidence of infectious insults in the pathogenesis and pathophysiology of schizophrenia. Am J Psychiatry: 2011; 168 764 766
98. Steiner J. et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. World J Biol Psychiatry: 2011; 13 482 492
99. Steiner J. et al. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res: 2008; 42 868 876 (Pubitemid 351787739)
100. Doorduin J. et al. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med: 2009; 50 1801 1807
101. van Berckel B. N. et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry: 2008; 64 820 822
102. Fusar-Poli P. et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev: 2011; 35 1175 1185
103. Fusar-Poli P. et al. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. Neuroimage: 2011; 55 320 328
104. Ho B. C. et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry: 2003; 60 585 594
105. Davis K. L. et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry: 2003; 60 443 456 (Pubitemid 36539053)
106. Garver D. L., Holcomb J. A., Christensen J. D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacol: 2008; 11 49 61
107. Grant J. K. et al. Persistent adeno-associated virus 2 and parvovirus B19 sequences in post-mortem human cerebellum. Cerebellum: 2009; 8 490 498
108. Pugliese A. et al. Parvovirus B19 and immune disorders. Cell Biochem Funct: 2007; 25 639 641 (Pubitemid 351202350)
109. Schmitt A. et al. Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci: 2011; 261 02 150 154
110. Uranova N. A. et al. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry: 2010; 11 567 578
111. Nieratschker V., Nothen M. M., Rietschel M. New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? Front Behav Neurosci: 2010; 4 23
112. Huber G., Gross G., Schüttler R. Schizophrenia. Clinical course and social psychiatric long term examinations of schizophrenic patients hospitalized in Bonn from 1945-1959. Monogr Gesamtgeb Psychiatr Psychiatry Ser: 1979; 21 1 399
113. Muller N. et al. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry: 2002; 159 1029 1034 (Pubitemid 34586950)
114. Laan W. et al. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry: 2010; 71 520 527
115. Bechter K. et al. Cerebrospinal fluid filtration in a case of schizophrenia related to "subclinicalo" Borna disease virus encephalitis. In: Müller N. (ed) Psychiatry, Psychoneuroimmunology and Viruses. Key Top Brain Res. Wien Springer: 1999; 19 35
116. Knight J. G. et al. Rationale for a trial of immunosuppressive therapy in acute schizophrenia. Mol Psychiatry: 2007; 12 424 431 (Pubitemid 46652460)
117. Ehrenreich H. et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain: 2007; 130 2577 2588 (Pubitemid 47511714)
118. Ehrenreich H. et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry: 2007; 12 206 220 (Pubitemid 46160985)
119. Ehrenreich H. et al. Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. J Ren Nutr: 2008; 18 146 153 (Pubitemid 350251844)
120. Oruch R. et al. An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes? J Chem Biol: 2010; 3 67 88
121. Macdowell K. S. et al. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation. Int J Neuropsychopharmacol: 2013; 16 121 135
122. Sy M. et al. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol: 2011; 178 2811 2822
123. Reiber H., Otto M., Bechter K. Crash Course: Cerebrospinal Fluid Diagnostics for Psychiatrists and Neurologists. Cerebrospinal fluid analysis for diagnosis of non-inflammatory, dementive and psychiatric diseases. Acta Neuropsychiatrica: 2009; 21 02 58 61
124. Reiber H., Peter J. B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci: 2001; 184 101 122 (Pubitemid 32178265)
125. Reiber H., Albaum W. Statistical evaluation of intrathecal protein synthesis in CSF/Serum quotient diagrams. Acta Neuropsychiatrica: 2008; 20 01 48 49
126. Bechter K. et al. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res: 2010; 44 321 330
127. Maxeiner H. G. et al. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun: 2009; 23 134 142
128. Kuehne L. K. et al. Cerebrospinal fluid neopterin is brain-derived and not associated with blood CSF barrier dysfunction. submitted
129. Muller N., Schwarz M. J. Immune System and Schizophrenia. Curr Immunol Rev: 2010; 6 213 220
130. Agnati L. F., Bjelke B., Fuxe K. Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med Res Rev: 1995; 15 33 45
131. Schwartz M., Shechter R. Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease. Mol Psychiatry: 2010; 15 342 354
132. Weller R. O. et al. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol: 2009; 117 1 14
133. Weller R. O. et al. Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis. Pathophysiology: 2010; 17 295 306
134. Pollay M. The function and structure of the cerebrospinal fluid outflow system. Cerebrospinal Fluid Res: 2010; 7 9
135. Johanson C. E. et al. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res: 2008; 5 10
136. Cserr H. F., Knopf P. M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today: 1992; 13 507 512
137. Andreasen N. Neuroimaging of schizophrenia: commentary. in Shenton M. E., Turetsky B. I. (ed) Understanding Neuropsychiatric Disorders - Insights from Neuroimaging. New York Cambridge University Press: 2011; 88
138. Mulert C. et al. Hearing voices: A role of interhemispheric auditory connectivity? World J Biol Psychiatry: 2012; 13 153 158
139. Strik C. et al. Intracranial oscillations of cerebrospinal fluid and blood flows: analysis with magnetic resonance imaging. J Magn Reson Imaging: 2002; 15 251 258 (Pubitemid 34195120)
140. Bechter K. The peripheral cerebrospinal fluid outflow pathway - physiology and pathophysiology of CSF recirculation: a review and hypothesis. Neurol Psychiatry Brain Res: 2011; 17 51 66
141. Kong L. et al. Neurological soft signs and gray matter changes: a longitudinal analysis in first-episode schizophrenia. Schizophr Res: 2012; 134 27 32
142. Meltzer H. Y., Crayton J. W. Subterminal motor nerve abnormalities in psychotic patients. Nature: 1974; 249 373 375
143. Dale R. C. et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain: 2004; 127 21 33 (Pubitemid 38055343)
144. Dalmau J. Anti-NMDAR and other synaptic mechanisms of autoimmune encephalitis. 8th International Congress on Autoimmunity. 2012
145. Dalmau J. et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol: 2011; 10 63 74
146. Irani S. R., Vincent A. The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. Arq Neuropsiquiatr: 2012; 70 300 304
147. Heuser M. et al. Neurological signs and morphological cerebral changes in schizophrenia: An analysis of NSS subscales in patients with first episode psychosis. Psychiatry Res: 2011; 192 69 76
148. Schwartz M., Kipnis J. A conceptual revolution in the relationships between the brain and immunity. Brain Behav Immun: 2011; 25 817 819
149. Reiber H. Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler: 1998; 4 99 107 (Pubitemid 28410032)
150. Schmitt M. et al. Spreading of Acute Myeloid Leukemia Cells by Trafficking along the Peripheral Outflow Pathway of Cerebrospinal Fluid. Anticancer Res: 2011; 31 2343 2345
151. Fatemi S. H., Folsom T. D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull: 2009; 35 528 548
152. Engelhardt B., Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. semin Immunopathol: 2009; 31 497 511
153. Bechmann J. et al. What is the blood-brain barrier (not)? Trends Immunol: 2007; 28 5 11
154. Wolburg H., Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol: 2010; 119 75 88
155. Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunktion in neurological diseases. J Neurol Sci: 1994; 122 189 203 (Pubitemid 24097269)